Thomas J. Fitzgerald

UMass Memorial Medical Center

Thomas J. FitzGerald, M.D. Department of Radiation Oncology University of Massachusetts Medical School 55 Lake Avenue North Worcester, MA 01655 (774) 442-2062 TJ.FitzGerald@umassmemorial.org Education M.D., University of Massachusetts Medical School, Worcester, MA 1980 B.S., Biology, University of San Francisco, San Francisco, CA 1975 Postdoctoral Training Residency, Harvard Medical School/Dana Farber Cancer Institute, Boston, MA 1981-1984 Academic Appointments Professor, Department of Radiation Oncology, University of Massachusetts Medical School, Worcester, MA 2004 - Present Professor, Radiology, Pediatrics, Obstetrics/Gynecology, and Cancer Biology University of Massachusetts Medical School, Worcester, MA 1993 - Present Associate Professor, Department of Radiation Oncology, University of Massachusetts Medical School, Worcester, MA 1988-1993 Assistant Professor, Department of Radiation Oncology, University of Massachusetts Medical School, Worcester, MA 1985 - 1988 Instructor, Department of Radiation Oncology, University of Massachusetts Medical School, Worcester, MA 1984 - 1985 Leadership Positions Director, Imaging and Radiation Oncology Core Group- Rhode Island, Department of Radiation Oncology, University of Massachusetts Medical School, Lincoln, RI 2014- Present Director, Department of Radiation Oncology, Affiliated Sites, MA 2011- Present Chair, Department of Radiation Oncology, University of Massachusetts Medical School, Worcester, MA 2004- Present Director, Quality Assurance Review Center, Department of Radiation Oncology, University of Massachusetts Medical School, Worcester, MA 1998 - Present Deputy Director, Quality Assurance Review Center Department of Radiation Oncology, Brown University, Providence, RI 1996 - 1998 Associate Director, Cancer Center, UMass Memorial Health Care Systems, Worcester, MA 1994 - Present Director, Department of Radiation Oncology, University of Massachusetts Medical School, Worcester, MA 1993 - 2003 Director, Department of Radiation Oncology, UMass Memorial Health Care Systems, Worcester, MA 1993 - Present Clinical Director, Department of Radiation Oncology UMass Memorial Health Care Systems, Worcester, MA 1989 - 1993 Honors and Awards Molseed Graduation Award (University of San Francisco) 1975 Cum Laude, Humanities Program (University of San Francisco) 1975 Clinical Honors in Medicine, Pediatrics, Radiology, Pulmonary Medicine (University of San Francisco – Community Medicine, Cardiology, Nephrology and Rheumatology) 1980 Outstanding Intern (George Washington University Hospital) 1984 Annual Essay Award for paper in radiation biology (American Society of Therapeutic Radiologists and Oncologists) 1984 Alumni Distinguished Service Award (University of Massachusetts Medical School) 2019 Editorial Responsibilities Cancer Concepts: A Guidebook for the Non-Oncologist, Editor 2019- Asian Journal of Andrology, Reviewer 2009 Frontiers in Oncology, Associate Editor 2011 - JAMA Oncology, Reviewer 2017 Educational Activities Educational Administration and Leadership Director, Department of Radiation Oncology, IMRT School 2006 Director, Department of Radiation Oncology, Radiation Therapy School 1989- Director, Medical Student Rotations and Student Oncology Fellowships 1985- Grants Current NIH/NCI CA180803 Followill (PI) Imaging and Radiation Oncology Core Group Role: PI 2014- NIH/NCI/MGH NCT01696721 Yock (PI) Pediatric Proton Consortium Registry Role: Co-Investigator 2012 - 2014 Selected Completed NIH/NCI CA029511 FitzGerald (PI) Quality Assurance Review Center (QARC) Role: PI 2007 - 2014 NIH/NCI/NWU CA159547 Kalapurakal (PI) Cardiac Sparing Whole Lung IMRT in Children and Young Adults with Lung Metastases: A Feasibility Study Role: Co-Investigator 2011 - 2013 NIH/NCI/BAH/EmoryU caBIG-IMG-109-02-06282008 Saltz (PI) Clinical Trials Tools Integration Role: Co-Investigator 2008 - 2009 DAMD/UMMS PC040221 Languino (PI) In Vitro Modulation of Prostate Cancer Cell Proliferation by Intergrins and Type 1 Insulin – Like Growth Factor Receptor Role: Co-Investigator 2005 - 2008 Clinical Practice Certification and Licensure Diplomate, AB Radiology 1984 Massachusetts Medical License 1980 Publications Selected peer-reviewed publications Lujan-Hernandez J, Chin MS, Perry DJ, Chappell A, Lancerotto L, Yu N, Slamin RP, Bannon E, Fitzgerald TJ, Lalikos JF. Increasing fat graft retention in irradiated tissue after preconditioning with external volume expansion. Plast Reconstr Surg. 145(1):103-112. (2020). FitzGerald TJ, Bishop-Jodoin M, Laurie F, Lukez A, O'Loughlin L, Sacher A. Treatment toxicity: Radiation. Hematol Oncol Clin North Am. 33(6):1027-1039. (2019). Elaimy AL, Amante JJ, Zhu LJ, Wang M, Walmsley CS, FitzGerald TJ, Goel HL, Mercurio AM. The VEGF receptor neuropilin 2 promotes homologous recombination by stimulating YAP/TAZ-mediated Rad51 expression. Proc Natl Acad Sci USA. 116(28):14174-14180. (2019). Prior F, Almeida J, Kathiravelu P, Kurc T, Smith K, Fitzgerald TJ, Saltz J. Open access image repositories: high-quality data to enable machine learning research. Clin Radiol. (19)30169-2. (2019). Elhalawani H, Elgohari B, Lin TA, Mohamed ASR, Fitzgerald TJ, et al. An in-silico QA study of contouring target volumes in thoracic tumors within a cooperative group setting. Clin Transl Radiat Oncol. 15:83-92. (2019). Fitzgerald TJ. Optimisation of adaptive therapy for advanced Hodgkin lymphoma. Lancet Oncol. (2):167-168. (2019). Rao A, Chen Q, Million L, Spunt S, FitzGerald TJ, et al. Preoperative IMRT compared to three-dimensional conformal radiotherapy for high-grade extremity sarcomas in children: Analysis of COG ARST0332. Int J Radiat Oncol Biol Phys. 103(1):38-44. (2019). Kalapurakal JA, Gopalakrishnan M, Walterhouse DO, Rigsby CK, Rademaker A, Helenowski I, Kessel S, Morano K, Laurie F, Ulin K, Esiashvili N, Katzenstein H, Marcus K, Followill D, Wolden SL, Mahajan A, Fitzgerald TJ. Cardiac-sparing whole lung IMRT in patients with pediatric tumors and lung metastasis: Final report of a prospective multicenter clinical trial. Int J Radiat Oncol Biol Phys. 103(1):28-37. (2019). FitzGerald TJ, Bishop-Jodoin M, Laurie F, O’Meara E, Davis C, et al. Importance of imaging in radiation oncology clinical trials for the NCTN. Int J Radiat Oncol Biol Phys. 102(4):775-782. (2018). FitzGerald TJ, Rosen MA, Bishop-Jodoin M. The influence of imaging in the modern practice of radiation oncology. Int J Radiat Oncol Biol Phys. 102(4):680-682. (2018). Kalapurakal JA, Gopalakrishnan M, Mille M, Helenowski I, Peterson S, Rigsby C, Laurie F, Jung JW, Fitzgerald TJ, Lee C. Feasibility and accuracy of UF/NCI phantoms and Monte Carlo retrospective dosimetry in children treated on National Wilms Tumor Study protocols. Pediatr Blood Cancer. 65(12).e27395. (2018). Haas-Kogan D, Indelicato D, Paganetti H, Esiashviti N, Mahajan A, Yock T, Flampouri S, MacDonald S, Fouladi M, Stephen K, Kalapurakal J, Terezakis S, Kooy H, Grosshans D, Makrigiorgos, Mishra K, Young Poussaint T, Cohen K, FitzGerald T, et al. NCI workshop on proton therapy for children: Considerations regarding brainstem injury. Int J Radiat Oncol Biol Phys. 101(1):152-168. (2018). FitzGerald TJ, Bishop-Jodoin M. Hodgkin lymphoma: Differences in treatment between Europe and the United States/North America: Evolving trends in protocol therapy. Clin Med Insights Oncol. 12:1179554918754885. (2018). Zhang S, Gupta S, Fitzgerald TJ, Bogdanov AA Jr. Dual radiosensitization and anti-STAT3 anti-proliferative strategy based on delivery of gold nanoparticle - oligonucleotide nanoconstructs to head and neck cancer cells. Nanotheranostics. 2(1):1-11. (2018). Mendenhall NP, Fitzgerald TJ. Conventional RT compared with stereotactic conformal therapy-A rare and laudable randomized trial. JAMA Oncol. 3(10):1376-1377. (2017). Varlotto JM, DiMaio C, Grassberger C, Tangel M, Mackley H, Pavelic M, Specht C, Sogge S, Nguyen D, Glantz M, Saw C, Upadhyay U, Moser R, Yunus S, Rava P, Fitzgerald TJ, et al. Multi-modality management of craniopharyngioma: Review of various treatments and outcomes. Neuro Oncol. 3(3):173-187. (2016). FitzGerald TJ, Bishop-Jodoin M, Followill DS, Galvin J, Knopp MV, et al. Imaging and data acquisition in clinical trials for RT. Int J Radiat Oncol Biol Phys. 94(2):404-11. (2016). Chin MS, Freniere BB, Lancerotto L, Lujan-Hernandez J, Saleeby JH, Lo YC, Orgill DP, Lalikos JF, Fitzgerald TJ. Hyperspectral Imaging as an early biomarker for radiation exposure and microcirculatory damage. Front Oncol. 5:232. (2015). Dharmarajan KV, Friedman DL, FitzGerald TJ, McCarten KM, Constine LS, et al. RT QA report from COG AHOD0031. Int J Radiat Oncol Biol Phys. doi: 10.1016/j.ijrobp.2014.11.034 (2015). Moni J, Saleeby J, Bannon E, Lo YC, Fitzgerald TJ. Dosimetric impact of the AeroForm tissue expander in postmastectomy RT: An ex vivo analysis. Prac Rad Onc. 5(1):e1-8. (2015). Sioshansi S, Rava PS, Karam AR, Lithgow M, Ding L, Xing W, FitzGerald TJ. Diaphragm injury after liver stereotactic body RT. Pract Radiat Oncol. 4(6):e227-30. (2014). FitzGerald TJ. A new model for imaging and RT QA in the NCTN of the NCI. Int J Radiat Oncol Biol Phys. 88(2):272-3. (2014). Chin MS, Freniere BB, Bonney CF, Lancerotto L, Saleeby JH, Lo YC, Orgill DP, Fitzgerald TJ, Lalikos JF. Skin perfusion and oxygenation changes in radiation fibrosis. Plast Reconstr Surg. 131(4):707-16. (2013). Fitzgerald TJ, Bishop-Jodoin M, Bosch WR, Curran WJ, Followill DS, et al. Future vision for the QA of oncology clinical trials. Front Oncol. 3:31. (2013). Ding L, Lo YC, Kadish S, Goff D, Pieters RS, Graeber G, Uy K, Quadri S, Moser R, Martin K, Day J, Fitzgerald TJ. VMAT for pulmonary SBRT in patients with lesions in close approximation to the chest wall. Front Oncol. 3:12 (2013). Followill DS, Urie M, Galvin JM, Ulin K, Xiao Y, Fitzgerald TJ. Credentialing for participation in clinical trials. Front Oncol. 2:198. (2012). Donahue B, Marymont MA, Kessel S, Iandoli MK, Fitzgerald T, et al. RT quality in CCG/POG intergroup 9961: implications for craniospinal RT and posterior fossa boost in future medulloblastoma trials. Front Oncol. 2:185. (2012). Tebbi CK, Mendenhall NP, London WB, Williams JL, Hutchison RE, Fitzgerald TJ, et al. Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: Report from COG. Pediatr Blood Cancer. 59(7):1259-65. (2012). Chin MS, Freniere BB, Lo YC, Saleeby JH, Baker SP, Strom HM, Ignotz RA, Lalikos JF, FitzGerald TJ. Hyperspectral imaging for early detection of oxygenation and perfusion changes in irradiated skin. Journal of Biomedical Optics 17(2):026010 (2012). Fitzgerald TJ. What we have learned: impact of quality from a clinical trials perspective. Semin Radiat Oncol. 22(1):18-28 (2012). Mayo CS, Ding, L Addesa A, Kadish S, Fitzgerald TJ, Moser R. Initial experience with volumetric IMRT (RapidArc) for intracranial SRS. Int J Radiat Oncol Biol Phys. 78(5):1457-66. (2010). Peters L, O’Sullivan B, Giralt J, Fitzgerald TJ, Trotti A, et al. Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer- results from TROG 02.02. J Clin Oncol. 28(18):2996-3001. (2010). Fitzgerald TJ, Wang T, Goel HL, Huang J, Stein G, et al. Prostate carcinoma and RT: therapeutic treatment resistance and strategies for targeted therapeutic intervention. Expert Rev Anticancer Ther. 8(6):967-74. (2008). Fitzgerald TJ, Jodoin MB, Tillman G, Aronowitz J, Pieters R, et al. RT toxicity to the skin. Dermatol Clin. 26(1):161-72. (2008). Bogart JA, Watson D, McClay EF, Evans L, Herndon JE, Laurie F, Seagren SL, Fitzgerald TJ, Vokes E, Green MR. Interruptions of once-daily thoracic radiotherapy do not correlate with outcomes in limited stage SCLC: analysis of CALGB phase III trial 9235. Lung Cancer. 62(1):92-98. (2008). FitzGerald TJ, Urie M, Ulin K, Laurie F, Yorty J, et al. Processes for quality improvements in radiation oncology clinical trials. Int J Radiat Oncol Biol Phys. 71(1Suppl):S76-9. (2008). Mayo CS, Urie MM, Fitzgerald TJ, Ding L, Lo YC, Bogdanov M. Hybrid IMRT for treatment of cancers of the lung and esophagus. Int J Radiat Oncol Biol Phys. 71(5): 1408-18. (2008). FitzGerald TJ, Aronowitz J, Cicchetti MG, Fisher G, Kadish S, et al. Effect of RT on normal tissue function. Hematol Oncol Clin North Am. 20(1):141-63. (2006). Mayo CS, Urie M, FitzGerald TJ. Hybrid IMRT plans- concurrently treating conventional and IMRT beams– for improved breast irradiation and reduced planning time. Int J Rad Oncol Bio Phys. 61(3):922-32. (2005). Reznik J, Cicchetti MG, Degaspe B, FitzGerald TJ. Analysis of axillary coverage during tangential RT to the breast. Int J Radiat Oncol Biol Phys, 61(1):163-68. (2005). Mayo C, Lo YC, FitzGerald TJ, Urie M. Forward-planned, multiple-segment, tangential fields with concomitant boost in breast cancer treatment. Med Dosim. 29(4):265-70. (2004). Urie M, FitzGerald TJ, Followill D, Laurie F, Marcus R, Michalski J. Current calibration, treatment, and treatment planning techniques among institutions participating in COG. Int. J. Rad. Oncol. Bio. Phys. 55(1):245-60. (2003). Urie M, Lo YC, Litofsky S, FitzGerald TJ. Miniature multileaf collimator as an alternative to traditional circular collimators for SRS and stereotactic radiotherapy. Stereotact Funct Neurosurg 76(1):47-62. (2001). Lo YC, Yasuda G, FitzGerald TJ, Urie M. Intensity modulation for breast treatment using static multi-leaf collimators. Int J Rad Onc Bio Phys. 46(1):187-94. (2000). Greenberger J, Leif J, Crawford D, Anklesaria P, English D, Sakakeeny M, Rubin J, Pierce J, Shadduck R, FitzGerald TJ. Humoral and cell surface interactions during gamma-irradiation leukemogenesis in vitro. Exp Hematol. 20(1):92-102 (1992). Das IJ, Kase KR, Copeland JF, Fitzgerald TJ. Electron beam modifications for treatment of superficial malignancies. Int J Radiat Oncol Biol Phys. 21(6):1627-34. (1991). Greenberger JS, Wright E, Henault S, Anklesaria P, Leif J, Sakakeeny MA, FitzGerald TJ, et al. Hematopoietic stem cell- and marrow stromal cell-specific requirements for gamma irradiation leukemogenesis in vitro. Exp Hematol. 18(5):408-15. (1990). Santucci MA, FitzGerald TJ, Harigaya K, Woda B, Sakakeeny MA, et al. Gamma-irradiation response of cocultivated bone marrow stromal cell lines of differing intrinsic radiosensitivity. Int J Radiat Oncol Biol Phys. 18(5):1083-92. (1990). Selected Books & Chapters FitzGerald TJ, Bishop-Jodoin M, Urie M, Ulin K, Ibbott G, et al. Quality Assurance of Clinical Trials in the Management of Cancer in the Head and Neck. In Head and Neck Cancer: Multimodality Management. Jacques Bernier, Ed. New York, NY. Springer. 687-94 (2011). FitzGerald TJ, Bishop-Jodoin M, Followill DS, Galvin JM, Knopp MV, et al. Head and Neck Quality Assurance In: Bernier J, ed. Head and Neck Cancer. 845-59. Cham, Switzerland: Springer International Publishing AG. (2016). FitzGerald TJ, Bishop-Jodoin M, Laurie F, Sacher A, Aghababian RV, Dickson E. Treatment Toxicity: Radiation. In: Todd K., Thomas, Jr. C. (eds) Oncologic Emergency Medicine. 407-419. Cham, Switzerland: Springer International Publishing. (2016). FitzGerald TJ, Bishop-Jodoin M, Laurie F, Riberdy C, Aronowitz JN, et al. Radiation Therapy. In Cancer. Stein G. (2018). FitzGerald TJ, Bishop-Jodoin M, Laurie F, Iandoli M, Elaimy M, et al. Treatment Toxicity: Radiation [Online First]. In: Emergency Medicine and Trauma. IntechOpen (2019). FitzGerald TJ, Bishop-Jodoin M, Laurie F, Hanusik R, Iandoli M, et al. Acquisition and Management of Data for Translational Science in Oncology. In: Translational Research in Cancer. IntechOpen (2019). Invited Presentations International FitzGerald TJ, Bishop-Jodoin M, Ulin K, Urie M, Kessel S, et al. Establishing an integrated database for distributed review of imaging, RT, and pathology objects. Fourth International Conference on Translational Research and Pre-Clinical Strategies in Radiation Oncology, Geneva, Switzerland. 2009 FitzGerald TJ. Setting endpoints and biomarkers in imaging testing. Fundamentals & Practical Aspects of Imaging in Clinical Trials. Institute for International Research. San Francisco, CA. 2007 Fitzgerald TJ, Mayo C, Lo YC, Urie M. Forward planning IMRT using concomitant boost for the treatment of breast cancer. Radiological Society of North America Annual Meeting, Chicago, IL. Med Dosim. 29(4):265-70. 2002 Other Selected Presentations, Posters & Abstracts International Hua CH, Vern-Gross TZ, Hess CB, Olch AJ, Sathiaseelan V, Alaei P, Deng J, Ulin K, Gopalakrishnan M, Donaldson SS, FitzGerald TJ, et al. Practice patterns of pediatric image-guided radiotherapy: COG Group report. Int J Radiat Oncol Biol Phys. 105(1S):S187. #1154. 2019 Kalapurakal JA, Gopalakrishnan M, Jung JW, Peterson S, Leisenring W, Laurie F, Rigsby C, Lee C, Fitzgerald T, Lee C. Accuracy of a computational human phantom model for retrospective 3-dimensional target-organ dosimetry for late effects study of patients on National Wilms tumor study protocols. Int J Radiat Oncol Biol Phys. 96(2S):S229. 2016 Kalapurakal JA, Gopalakrishnan M, Walterhouse DO, Helenowski I, Rigsby C, Kessel S, Laurie F, Katzenstein H, Ulin K, Rademaker A, Followill D, Morano K, Marcus KJ, Esiashvili N, Wolden SL, Mahajan A, Fitzgerald T. Final report of a prospective clinical trial of cardiac sparing whole-lung IMRT in patients with metastatic pediatric tumors. Int J Radiat Oncol Biol Phys. 96(2S):S118-S119. 2016 Sioshansi S, Rava P, Yu E, Fitzgerald TJ. Stereotactic body radiotherapy for hepatocellular carcinoma: comparing clinical and pathologic response. Annual Meeting, American Society of Therapeutic Radiation Oncology. Boston, MA. Int J Radiat Oncol Biol Phys. 96(2):E201. 2016 Michalski J, Vezina G, Burger P, Gajjar A, Pollack I, Merchant T, Fitzgerald TJ, et al. Preliminary results of COG ACNS0331: Phase III trial of involved field radiotherapy and low dose craniospinal irradiation with chemotherapy in average risk medulloblastoma: Report from COG. Neuro Oncol. 18(S3):122. MB-109. 2016 Pieters RS, Kuo i-L, Bornstein BA, FitzGerald TJ. Impact of radiotherapy technique on normal tissue dose in treatment of spinal vertebral metastases. J Clin Oncol 32(suppl 31);abstr 179). 2014 Wu K, Rava P, Sioshansi S, Fitzgerald TJ, DiPetrillo T, et al. Major criteria to select patients for SRS following resection of brain metastases. Neuro Oncol. 16(5):RT-38. 2014 Chin MS, Harris LE, Connor NM, Saleeby JH, Wyman A, FitzGerald GA, Lo YC, FitzGerald TJ, Laliko JF. Hyperspectral imaging for prospective clinical evaluation of skin perfusion after RT. Wound Repair Regen. 22(2): A35. 2014 Janko M, Sioshansi S, Bonavitacola PJ, Rava P, FitzGerald TJ. Breast axillary lymph node dose with whole breast radiation using 3D conformal and IMRT. Annual Meeting, Radiological Society of North America. Chicago, IL. http://archive.rsna.org/2013/13021099.html. 2013 Dharmarajan KV, Friedman DL, FitzGerald T, McCarten KM, Constine LS, et al. RT QA on AHOD0031: Report from QARC and COG. Int J Radiat Oncol Biol Phys. 84(3): S162. 2012 Ding L, Lo YC, Kadish S, Goff D, Pieters R, FitzGerald TJ. Evaluation of the use of VMAT technology for pulmonary SBRT in patients with lesions on close approximation to the chest wall. SRS/SBRT Scientific Meeting, Carlsbad, CA. 2012 Chin MS, Freniere BB, Bonney CF, Lancerotto L, Saleeby JH, Lo Y, Ignotz RA, Orgill DP, Fitzgerald TJ, Lalikos JF. Characterization of chronic perfusion and oxygenation changes in irradiated skin. Wound Repair Regen. 20(2):A18. 2012 Mulhern JP, Fitzgerald T, Bosch W, Chen J, Siegel E, et al. Bioinformatics support of cross correlation of images with RT objects and clinical meta-data. American Society for Radiation Oncology 53rd Annual Meeting, Miami Beach, FL. Int J Radiat Oncol Biol Phys. 81(2):S160. 2011 FitzGerald TJ, Bishop-Jodoin M, Laurie F, Hanusik R, Urie MM, et al. Integrating diagnostic imaging and radiotherapy objects into a single case management system for clinical research. American Society for Therapeutic Radiology and Oncology Cancer Imaging and RT Symposium, Atlanta, GA. 2011 Urie M, FitzGerald TJ, Hanusik R, Jodoin M, Kessel S, et al. QARC QA of imaging and RT improves protocol compliance in advanced technology cancer clinical trials. Imaging for Treatment Assessment in Radiation Therapy Meeting, National Harbor, Maryland. AbstractID: 14288. 2010 Fitzgerald TJ, Bishop-Jodoin M, Laurie F, Hanusik R, Cicchetti M, et al. Acquiring and reviewing imaging, RT, and pathology microarray objects in an integrated database. 4th ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer, Hollywood, FL. 2010 Saleeby J, Ebert R, FitzGerald TJ, Mayo CS, Pieters RS. Whole-ventricular irradiation of pediatric patients using opposed laterals, 3D conformal and IMRT techniques: a dose volume histogram comparison. Radiological Society of North America (RSNA) Annual Meeting, Chicago, IL. 2009 FitzGerald TJ, Hanusik R, Laurie F, McCarten K, Bishop-Jodoin ML, Cicchetti MG. An integrated informatics system for acquiring, managing and reviewing imaging and RT. Radiological Society of North America Annual Meeting, Chicago, IL. 2009 Urie MM, Ulin K, FitzGerald TJ, Yorty J, Bertsch K, et al. Dosimetric comparison of RT planning techniques by multiple international institutions for a benchmark head and neck case. American Society for Radiation Oncology 50th Annual Meeting, Boston, MA. Int J Radiat Oncol Biol Phys. 72(1): S590-91. 2008 Ulin K, Yorty J, Hanusik R, Urie M, Bosch WR, Apte A, Khullar D, Deasy JO, Fitzgerald TJ. Use of CERR at QARC to assess protocol compliance of RT treatment plans submitted in digital format. American Society for Radiation Oncology 50th Annual Meeting, Boston, MA. Int J Radiat Oncol Biol Phys. 72(1): S673. 2008 FitzGerald TJ, Urie M, Ulin K, Laurie F, Yorty J, et al. Processes for quality improvements in radiation oncology clinical trials. Quality Assurance of RT: Challenges of Advanced Technologies Symposium. Int J Radiat Oncol Biol Phys. 71(1): S76-79. 2008 FitzGerald TJ. Current limitations & identification of key clinical needs: quality control for National Trials. SBRT. Rochester, NY. 2008 FitzGerald TJ. Data management for late effects of cancer treatment. Cancer Survivor Research and Education (CURED) Adverse Late Effects in Radiation Treatment . Rochester, NY. 2008 FitzGerald TJ. QA in clinical trials. EORTC-NCI Bethesda, MD. 2008 Mayo CS, Urie MM, Fitzgerald TJ, Ding L, Lo YC, Hybrid (static plus IMRT beams) treatment of cancers of the lung and esophagus. American Society for Radiation Oncology 49th Annual Meeting, Los Angeles, CA. Int J Radiat Oncol Biol Phys. 69 (3): S485-86. 2007 Sullivan DC, Schwartz LH, FitzGerald TJ, Heverhagen JT. Therapy assessment: Integrating MR response information within trials: a QA perspective. International Society for Magnetic Resonance in Medicine Scientific Meeting Seattle, WA. 2006 Blackstock A, Socinski MA, Fitzgerald TJ, Gu L, Rosenman J, et al. Initial pulmonary toxicity evaluation of chemoradiotherapy CRT utilizing 74 Gy 3-Dimensional thoracic radiation in Stage III NSCLC: a CALGB randomized phase II trial. Int J Radiat Oncol Biol Phys. 63:S43. 2005 Reznik J, Cicchetti MG, Degaspe B, Fitzgerald TJ. Analysis of axillary coverage during tangential RT to the breast. Int J Radiat Oncol Biol Phys. 61 (1):163-168. 2005 Mendenhall NP, Meyer J, Williams J, Tebbe C, Kessel S, Laurie F, Fitzgerald TJ. Impact of central QA review prior to RT on protocol compliance: COG 9426. 47th American Society of Hematology Annual Meeting and Exposition, Atlanta, GA. Blood (ASH Annual Meeting Abstracts) 106(11):753. 2005 Urie M, FitzGerald TJ, Followill D, Laurie F, Marcus R, Michalski J. Current calibration, treatment, and treatment planning techniques among institutions participating in COG. Int J Radiat Oncol Biol Phys. 55 (1):245-260. 2003 Lo Y, Mardirossian G, Cicchetti MG, McCauley S, Fisher G, FitzGerald TJ. Dose coverage evaluation and comparison between 2D and 3D planning for patients with breast cancer. American Society for Therapeutic Radiology and Oncology 44th Annual Meeting, New Orleans, LA. Int J Radiat Oncol Biol Phys. 54 (2) S:237. 2002 Reznik J, Cicchetti MG, DeGaspe B, FitzGerald TJ. Analysis of axillary coverage during tangential RT to the breast. American Society for Therapeutic Radiology and Oncology 43rd Annual Meeting, San Francisco, CA. Int J Radiat Oncol Biol Phys. 51(3) S1-6-7. 2001 Cicchetti MG, Bogart J, Lyss A, Turrisi A, Green M, Herndon M, Bushe S, Briggs K, Koehler I, Bertsch K, Laurie F, FitzGerald TJ. Spinal cord dose in limited stage SCLC: Preliminary QA review committee (QARC) report on CALGB 39808, using target thoracic radiotherapy doses of 60 – 70 Gy. Int J Radiat Oncol Biol Phys. 51(3)S1:356. 2001 FitzGerald, TJ, Mendenhall NP, Williams J, Constine LS, Laurie F, et al. RT QA in Hodgkin’s disease: intervention rate with pre-therapy central review. Fifth International Symposium on Hodgkins Lymphoma, Cologne, Germany. P-234 2001 Lo YC, Yasuda G, Fitzgerald TJ, Urie MM. Intensity modulation for breast treatment using static multi-leaf collimators. Int J Radiat Oncol Biol Phys. 46(1):187-194. 2000 Urtasun R, Mackie R, Fitzgerald TJ. Past, Present and Future of External Beam RT. Canadian Association of Radiation Oncologists (CARO), Edmonton Canada. 2000 FitzGerald TJ, Williams J, Laurie F, Kessel S, Ferree S, Mendenhall N. Problems in RT protocol compliance in Hodgkin's disease: Preliminary analysis of POG study 9426. Int J Radiat Oncol Biol Phys. 45(3S):391-392. 1999 Urie M, FitzGerald TJ. QA for 3D protocols: physics aspects. Pediatric Oncology Group Meeting, St. Petersburg, FL. 1997 Greenberger JS, Anklesaria P, Leif J, Sakakeeny M, English D, Kase K, Das I, Buckley C, Fitzgerald TJ. Indirect gamma irradiation leukemogenesis through bone marrow stromal cells. Int J Radiat Oncol Biol Phys. 21(S1):187-88. 1991 Recht L, FitzGerald TJ, Silver D, Straus G, Fram R, Egan G, Wilson J, Liepman M, Tak W. Pre-irradiation chemotherapy of malignant brain tumor. Int J Radiat Oncol Biol Phys. 12(S1):178. 1986 Committee Assignments National Quantitative Imaging for the Evaluation of Responses to Cancer Therapies (Chair), NBIB, Center for Scientific Review(CSR)/NIH 2013- Present Clinical and Translational Imaging Applications (Reviewer), NBIB, CSR/NIH 2013- Present NCI Special Emphasis Panel/Scientific Review Group (Invited Expert), NBIB, CSR/NIH 2012- Present NCI Special Emphasis Panels (Invited Expert), NBIB, CSR/NIH 2011- Present Quantitative Imaging Network Review Meeting (Chair), NBIB, CSR/NIH 2010- Present Quantitative Imaging for Evaluation of Responses to Cancer Therapies (Invited Expert), NBIB, CSR/NIH 2009- 2012 Clinical and Translational Science Awards (CTSAs) Imaging Committee (Invited Expert), National Center for Research Resources/NIH 2008- Present National Cancer Institute Special Emphasis Panel (Invited Expert), NBIB, CSR/NIH 2008 Emerging Oncology Technologies Study Section (Invited Expert), NBIB, CSR/NIH 2006- Present Imaging Technologies Study Section (Invited Expert), NBIB, CSR/NIH 2005- Present Genomes/ Proteomics Study Section(Invited Expert), NBIB, CSR/NIH 2004- Present

3chapters authored